Efficacy & Safety of Pharmacokinetically-Driven Dosing of Mycophenolate Mofetil for the Treatment of Pediatric Proliferative Lupus Nephritis- A Double-Blind Placebo Controlled Clinical Trial
Latest Information Update: 12 May 2025
At a glance
- Drugs Mycophenolate mofetil (Primary)
- Indications Lupus nephritis
- Focus Therapeutic Use
- Acronyms PLUMM
Most Recent Events
- 04 Mar 2025 Planned End Date changed from 1 Mar 2026 to 1 Jan 2027.
- 04 Mar 2025 Planned primary completion date changed from 1 Jul 2025 to 1 Jul 2026.
- 10 Jan 2024 Status changed from not yet recruiting to recruiting.